- Home
- HBIO vs CASI Comparison
HBIO vs CASI Comparison
Compare HBIO & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- CASI
- Stock Information
- Founded
- HBIO 1901
- CASI 1991
- Country
- HBIO United States
- CASI China
- Employees
- HBIO N/A
- CASI N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- CASI Health Care
- Exchange
- HBIO Nasdaq
- CASI Nasdaq
- Market Cap
- HBIO 19.6M
- CASI 20.5M
- IPO Year
- HBIO 2000
- CASI 1996
- Fundamental
- Price
- HBIO $0.45
- CASI $1.27
- Analyst Decision
- HBIO Buy
- CASI Strong Buy
- Analyst Count
- HBIO 2
- CASI 1
- Target Price
- HBIO $3.00
- CASI $4.00
- AVG Volume (30 Days)
- HBIO 1.2M
- CASI 42.8K
- Earning Date
- HBIO 08-11-2025
- CASI 08-15-2025
- Dividend Yield
- HBIO N/A
- CASI N/A
- EPS Growth
- HBIO N/A
- CASI N/A
- EPS
- HBIO N/A
- CASI N/A
- Revenue
- HBIO $91,397,000.00
- CASI $31,368,000.00
- Revenue This Year
- HBIO N/A
- CASI N/A
- Revenue Next Year
- HBIO $9.75
- CASI N/A
- P/E Ratio
- HBIO N/A
- CASI N/A
- Revenue Growth
- HBIO N/A
- CASI 8.39
- 52 Week Low
- HBIO $0.28
- CASI $1.09
- 52 Week High
- HBIO $3.48
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- HBIO 49.68
- CASI 39.21
- Support Level
- HBIO $0.39
- CASI $1.21
- Resistance Level
- HBIO $0.48
- CASI $1.44
- Average True Range (ATR)
- HBIO 0.03
- CASI 0.12
- MACD
- HBIO -0.00
- CASI 0.02
- Stochastic Oscillator
- HBIO 67.67
- CASI 48.78
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.